To mark International Women’s Day 2026, a new article in PharmaLive, authored by Sarah Tucker, Chief Operating Officer at Phastar, explores how visible, inclusive leadership and strong female representation across technical and executive teams are driving operational excellence, stronger decision-making, and improved outcomes in clinical research, while reinforcing the business case for diversity in a traditionally male-dominated sector.
”In clinical research, a sector traditionally dominated by men at senior levels, visible leadership matters. At Phastar, that progress is tangible. Women make up 56 percent of the organization’s technical teams and play a key role in shaping executive leadership, representing nearly half of the decision-makers guiding the organization, a strong benchmark in the CRO industry.”